Posted on 5 October 2012
The Workshop, which will be held at the Academy of Medical Sciences in London, involves participants representing the AMS, the ABPI, the MRC, ESRC and the MHRA. The main objectives are to understand the current regulatory environment in the UK/Europe and explore its suitability for the current R&D needs for cell-based regenerative medicine; the key areas of regulatory uncertainty and concern regarding the development of cell-based regenerative therapies; and the likely needs for the area regarding future scientific progress. A follow-up workshop is being planned for the spring in Toronto that will compare the European and North American regulatory systems. More details will be posted shortly.